New HOLO AI Insights utility goals to advance analysis of neuroanatomy using synthetic intelligence
DEERFIELD, In poor health., Might 08, 2023 (GLOBE NEWSWIRE) — Surgalign Holdings, Inc., (NASDAQ: SRGA) a worldwide medical know-how firm targeted on elevating the usual of care by driving the evolution of digital well being, is proud to announce at the moment, the discharge of HOLO™ AI Insights to be used in neurovascular analysis.
HOLO AI Insights, initially launched in March 2023 for spine imaging, allows prospects, companions, and medical researchers to reap the benefits of the Firm’s HOLO synthetic intelligence (AI) portfolio by a safe, extremely scalable cloud platform for automated evaluation of medical pictures. HOLO AI, Surgalign’s portfolio of AI know-how, makes use of convolutional neural community know-how to routinely section medical pictures, measure anatomic buildings, automate pedicle screw planning, and carry out different duties.
With this newest launch, HOLO AI Insights has developed to now tackle neurovascular analysis. This newest addition to the Firm’s portfolio, can analyze giant units of cranial MRI pictures, routinely determine 16 totally different buildings, and mixture the information for the person into configurable graphical and file codecs. The insights generated by these outcomes are believed to have a number of functions in inhabitants well being, medical analysis, and sooner or later, affected person care.
Surgalign has partnered with Dr. Brian Jankowitz, a fellowship educated cerebrovascular neurosurgeon, for neurovascular analysis with HOLO AI Insights. “Many of the AI work accomplished within the neurovascular house has targeted on acute care with CT imaging and doesn’t assist with measurement. HOLO AI Insights can automate volumetric evaluation of vascular buildings on MRI, which is a giant leap ahead in effectivity and extra relevant to longitudinal comparisons than different instruments obtainable at the moment,” stated Dr. Jankowitz. “I consider that in the end this know-how will each pace our workflow and enhance medical tips by offering a considerably extra detailed characterization of neurovascular buildings.”
Dr. Jankowitz, MD is a neurosurgery specialist with in depth expertise in Neurocritical Care Issues. He’s affiliated with the medical services Hospital of the College of Pennsylvania and Cooper College Hospital. He beforehand served as an affiliate professor of neurological surgical procedure on the College of Pittsburgh Faculty of Drugs and served as college of the UPMC Neurosurgery Division and UPMC Stroke Institute the place he specialised in each open and endovascular neurosurgery. Dr. Jankowitz earned a bachelor of science diploma from the College of Notre Dame and acquired his medical diploma from Temple College Faculty of Drugs.
“It’s an honor to accomplice with Dr. Jankowitz with a shared purpose of advancing know-how utilized by neuroanatomy researchers,” stated Terry Wealthy, President and Chief Govt Officer of Surgalign. “Amassing patient-specific medical info from a number of websites to generate inhabitants degree experiences utilizing AI know-how holds super promise to enhance our information of the mind. We consider processing bigger volumes of information is a useful step to generate reference info to assist medical professionals as we proceed to search for new methods to leverage our AI portfolio.”
HOLO AI additionally powers Surgalign’s HOLO Portal™ surgical steering system and HOLO AI Insights for Backbone. The addition of HOLO AI Insights for neuroanatomy is an additional step in Surgalign’s mission to rework affected person care with synthetic intelligence.
HOLO AI Insights shouldn’t be supposed for use for affected person therapy. Be taught extra at https://www.holo.ai.
About Surgalign Holdings, Inc.
Surgalign Holdings, Inc. is a worldwide medical know-how firm dedicated to the promise of digital well being to drive transformation throughout the surgical panorama. Uniquely aligned and resourced to advance the usual of care, the corporate is constructing applied sciences physicians and different well being suppliers will look to for what is really potential for his or her sufferers. Surgalign is concentrated on creating options that predictably ship superior medical and financial outcomes. Surgalign markets merchandise all through america and in roughly 50 international locations worldwide by an increasing community of high unbiased distributors. Surgalign is headquartered in Deerfield, IL, with business, innovation and design facilities in San Diego, CA, Warsaw and Poznan, Poland, and Wurmlingen, Germany. Be taught extra at www.surgalign.com and join on LinkedIn and Twitter.
Ahead Wanting Assertion
This press launch incorporates forward-looking statements primarily based on administration’s present expectations, estimates and projections about our business, our administration’s beliefs and sure assumptions made by our administration, and such forward-looking statements embody (amongst others) statements concerning anticipated future monetary and working efficiency (together with forecasted full-year income and variety of HOLO websites secured), product rationalization and expense discount initiatives and the outcomes thereof, potential third get together financing and anticipated money wants. Phrases resembling “anticipates,” “expects,” “intends,” “plans,” “believes,” “seeks,” “estimates,” variations of such phrases and related expressions are supposed to determine such forward-looking statements. The forward-looking statements will not be ensures of future efficiency and are primarily based on sure assumptions together with common financial situations, in addition to these throughout the Firm’s business, and quite a few different elements and dangers recognized within the Firm’s most up-to-date Type 10-Ok, 10-Q and different filings with the SEC. Our precise outcomes could differ materially from the anticipated outcomes mirrored in these forward-looking statements. Necessary elements that might trigger precise outcomes to vary materially from the anticipated outcomes mirrored in these forward-looking statements embody dangers and uncertainties referring to the next: (i) the Firm’s entry to ample working money circulation, commerce credit score, borrowed funds and fairness capital to fund its operations and pay its obligations as they turn out to be due, and the phrases on which exterior financing could also be obtainable, together with the affect of opposed traits or disruption within the world credit score and fairness markets; (ii) dangers referring to current or potential litigation or regulatory actions; (iii) the identification of management deficiencies, together with materials weaknesses in inside management over monetary reporting; (iv) common worldwide financial situations and associated uncertainties; (v) the continued affect of the COVID-19 and the Firm’s makes an attempt at mitigation, significantly in worldwide markets served by the Firm; (vi) the failure by the Firm to determine, develop and efficiently implement its strategic initiatives, significantly with respect to its digital surgical procedure technique; (vii) the reliability of our provide chain; (viii) our capacity to satisfy obligations, together with buy minimums, beneath our vendor and different agreements; (ix) whether or not or when the demand for procedures involving our merchandise will improve; (x) our monetary place and outcomes, whole income, product income, gross margin, and operations; (xi) failure to comprehend, or sudden prices in searching for to comprehend, the anticipated advantages of the Holo Surgical Inc. (“Holo Surgical”) and Inteneural Networks Inc. (“INN”) acquisitions, together with the failure of Holo Surgical’s and INN’s services to be satisfactorily developed or obtain relevant regulatory approvals or on account of the failure to commercialize and distribute its merchandise; (xii) the failure to successfully combine Holo Surgical’s and INN’s operations with these of the Firm, together with: retention of key personnel; the impact on relationships with prospects, suppliers, and different third events; and the diversion of administration time and a spotlight to the mixing; (xiii) the variety of shares and amount of money that might be required in reference to any post-closing milestone funds, together with on account of adjustments within the buying and selling worth of the Firm’s frequent inventory and their impact on the amount of money wanted by the Firm to fund any post-closing milestone funds in reference to the acquisitions; (xiv) the continuation of latest high quality points with respect to our world provide chain; (xv) the impact and timing of adjustments in legal guidelines or in governmental laws; and (xvi) different dangers described in our public filings with the SEC. These elements needs to be thought-about fastidiously, and undue reliance shouldn’t be positioned on the forward-looking statements. Every forward-looking assertion on this communication speaks solely as of the date of the actual assertion. Copies of the Firm’s SEC filings could also be obtained by contacting the Firm or the SEC or by visiting Surgalign’s web site at http://www.surgalign.com/ or the SEC’s web site at http://www.sec.gov/. We undertake no obligation to replace these forward-looking statements besides as could also be required by regulation.
Investor and Media Relations Contact:
+1 917 887 8434